leveraging icer analytics: gene therapies for hemophilia a and b
Published 1 year ago • 138 plays • Length 46:56Download video MP4
Download video MP3
Similar videos
-
1:34:44
icer ctaf public meeting on hemophilia a & b: evidence presentation
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
18:10
gene therapy for hemophilia
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
1:03:17
hemophilia gene therapy value assessment: methodological challenges and recommendations
-
2:33
gene therapy for hemophilia a
-
1:00:47
icer's barriers to fair access webinar: evaluating 2022 coverage policies
-
6:18
current update of clinical trials on gene therapy for hemophilia
-
1:03:24
icer valuing a cure meeting: questions about additional elements of value
-
0:51
empowering patients with hemophilia to make choices about gene therapy
-
1:45:37
icer new england cepac public meeting on treatments for multiple sclerosis: policy roundtable
-
46:56
an exploration of why men with severe haemophilia might not want gene therapy: the exigency study
-
1:20
hemophilia gene therapy: expectations for reliability and accessibility
-
49:50
gene therapy basics for hemophilia: what you need to know
-
3:17
gene therapy for hemophilia: efficacy and safety
-
3:08
hemophilia and gene therapy
-
22:48
gene therapy for treatment of hemophilia other strategies and targets
-
2:21
gene therapy for hemophilia b found safe and effective in first phase iii trial
-
50:15
hemophilia gene therapy- key components of clinical care